Tylosin is an antibiotic medication in the macrolide class commonly used in veterinary medicine to treat various bacterial infections in animals, particularly in livestock such as cattle, swine, poultry, and companion animals like dogs and cats. It is a crucial antibiotic medication used in veterinary medicine to treat bacterial infections in animals, contributing to the health and welfare of livestock and companion animals.
Sizing and Forecast
The tylosin market size has grown strongly in recent years. It will grow from $0.70 billion in 2023 to $0.74 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to increased livestock production, antibiotic growth promoters (agps), veterinary health awareness, government regulations and approvals, and increased prevalence of livestock diseases.
The tylosin market size is expected to see strong growth in the next few years. It will grow to $0.93 billion in 2028 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to rising global meat consumption, focus on animal health and welfare, expansion of livestock farming in emerging markets, regulatory changes and ban on antibiotic growth promoters, and growing demand for organic and antibiotic-free meat. Major trends in the forecast period include increasing demand for antibiotic alternatives, stringent regulatory policies, advancements in precision livestock farming, growth in the organic and antibiotic-free meat market, and expansion of veterinary services and infrastructure.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/tylosin-global-market-report
Segmentation & Regional Insights
The tylosin market covered in this report is segmented –
1) By Type: Tylosin Tartrate, Tylosin Phosphate, Other Types
2) By Application: Animal Feed Additives, Animal Drugs, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
North America was the largest region in the tylosin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tylosin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15946&type=smp
Major Driver Impacting Market Growth
The increase in meat production is expected to propel the growth of the tylosin market going forward. Meat production refers to raising, slaughtering, and processing animals to obtain meat for human consumption. The increase in meat production is due to consumer preferences for nutritious, ethically sourced food products and concerns about animal welfare and environmental sustainability. Tylosin is commonly used in livestock as an antibiotic to treat bacterial infections such as respiratory diseases and gastrointestinal issues, and it’s also used as a growth promoter in some regions. For instance, in February 2024, according to the Department for Environmental Food and Rural Affairs, a UK-based governmental department, total meat production in the US is at 4.2 million tonnes in 2022, representing an 18% increase from a decade earlier. Further, red meat production surged, with mutton and lamb experiencing the most significant growth at 2.9%. Additionally, home-fed production saw a slight uptick from 4,178 to 4,182 between 2020 and 2022. Therefore, the increasing demand for healthy livestock is driving the growth of the tylosin market.
Key Industry Players
Major companies operating in the tylosin market are Eli Lilly and Company, Zoetis Inc., Elanco Animal Health Inc., Ceva Santé Animale, Apeloa Pharmaceutical co. ltd, Phibro Animal Health Corporation, Shandong Lukang Pharmaceutical Co. Ltd, Vetoquinol S.A., Norbrook Inc., Qilu Animal Health Products Co. Ltd., Merck & Co. Inc., Hebei Veyong Animal Pharmaceutical, Suanfarma SA, Huvepharma AD, Rochem International Inc, AdvaCare Pharma, Ningxia Tairui Pharmaceutical Co. Ltd., HangZhou Think Chemical Co. Ltd., Vetgen Healthcare Pvt Ltd, Anhui Sinotech Industrial, Pucheng Chia Tai Biochemistry Co Ltd, All Chem Bio Sciences, Nestlife Science Pvt Ltd, Sunvet Pharma Private Ltd, BOC Sciences
The tylosin market report table of contents includes:
1. Executive Summary
2. Tylosin Market Characteristics
3. Tylosin Market Trends And Strategies
4. Tylosin Market – Macro Economic Scenario
5. Global Tylosin Market Size and Growth
……………..
32. Global Tylosin Market Competitive Benchmarking
33. Global Tylosin Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Tylosin Market
35. Tylosin Market Future Outlook and Potential Analysis
36. Appendix
Explore the trending research reports from TBRC:
https://topprnews.com/anticoccidial-drugs-market-size/
https://topprnews.com/biological-data-visualization-market-scope/
https://topprnews.com/global-cell-cryopreservation-market-growth/
https://goodprnews.com/anticoccidial-drugs-market-forecast/
https://goodprnews.com/biological-data-visualization-market-growth/
https://goodprnews.com/global-cell-cryopreservation-market-forecast/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
